Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography (Q44062349)

29 November 2017

title

Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography (English)

1 reference

29 November 2017

0 references

1 reference

1

Douglas S Hawkins

1 reference

29 November 2017

Joseph G Rajendran

2

1 reference

29 November 2017

Ernest U Conrad

series ordinal

3

1 reference

29 November 2017

James D Bruckner

series ordinal

4

1 reference

29 November 2017

Janet F Eary

series ordinal

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

94

1 reference

29 November 2017

issue

12

1 reference

29 November 2017

page(s)

3277-3284

1 reference

The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Imaging bone tumors in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

What does positron emission tomography offer oncology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Primary Osteogenic Sarcoma of the Femur: A Model for the Use of Preoperative Chemotherapy in High Risk Malignant Tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10599

7 January 2021

Identifiers

DOI

10.1002/CNCR.10599

1 reference

29 November 2017

1 reference